Search results
Madrigal Pharmaceuticals (NASDAQ:MDGL) Shares Gap Down to $244.35
ETF DAILY NEWS· 3 days agoMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report)’s stock price gapped down prior to trading on Wednesday . Madrigal Pharmaceuticals ...
Insider Sale: CEO Brian Goff Sells Shares of Agios Pharmaceuticals Inc (AGIO)
GuruFocus.com via Yahoo Finance· 2 days agoOn June 5, 2024, Brian Goff, Chief Executive Officer of Agios Pharmaceuticals Inc (NASDAQ:AGIO),...
Cyclacel Pharmaceuticals maintains $11 target, Buy rating By Investing.com
Investing.com· 6 days agoOn Monday, Roth/MKM maintained its Buy rating and $11.00 price target for Cyclacel Pharmaceuticals (...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stock Position Raised by California State Teachers...
ETF DAILY NEWS· 6 days agoCalifornia State Teachers Retirement System lifted its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 1.4% in the 4th quarter ...
Agios Pharmaceuticals Target of Unusually Large Options Trading (NASDAQ:AGIO)
ETF DAILY NEWS· 6 days agoAgios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) was the target of some unusual options trading activity on Monday. The Goldman Sachs Group increased ...
JMP Securities Reaffirms Market Outperform Rating for Crinetics Pharmaceuticals (NASDAQ:CRNX)
ETF DAILY NEWS· 5 days agoCrinetics Pharmaceuticals (NASDAQ:CRNX – Get Free Report)‘s stock had its “market outperform” rating reaffirmed by analysts at JMP Securities in a report ...
A Quick Glance At Apellis Pharmaceuticals Inc (NASDAQ: APLS) Stock: It Is up 52.22% From Its 52-Week...
Marketing Sentinel· 4 days agoDuring the last session, Apellis Pharmaceuticals Inc (NASDAQ:APLS)’s traded shares were 1.33 million, with the beta value of the company hitting 0.89. At ...
Phio Pharmaceuticals (NASDAQ:PHIO) Stock Price Up 2.5%
ETF DAILY NEWS· 3 days agoPhio Pharmaceuticals Corp. (NASDAQ:PHIO – Get Free Report) rose 2.5% during trading on Thursday . The company traded as high as $0.75 and last traded at ...
Insider Sale: Director David Guyer Sells Shares of EyePoint Pharmaceuticals Inc (EYPT) By GuruFocus
Investing.com· 5 days agoInsider Sale: Director David Guyer Sells Shares of EyePoint Pharmaceuticals Inc (EYPT)
Insider Sale: CEO Brian Goff Sells Shares of Agios Pharmaceuticals Inc (AGIO) By GuruFocus
Investing.com· 2 days agoOn June 5, 2024, Brian Goff, Chief Executive Officer of Agios Pharmaceuticals Inc (NASDAQ:AGIO),...